MECP2 antibodies are used in DNA methylation studies as well as research into Rett syndrome, a progressive neurological disorder caused by a mutation in the MECP2 gene. Now, a new study has been published by the laboratory where the Rett Syndrome gene was discovered, citing MECP2 as a critical factor in a number of other neurological conditions by its interaction with GABA.
